Analysis of pncA gene expression in pyrazinamide-resistant and multidrug-resistant <i>Mycobacterium tuberculosis</i>

Analysis of pncA gene expression in pyrazinamide-resistant and multidrug-resistant <i>Mycobacterium tuberculosis</i>

Objective To compare the expression levels of pncA gene in pyrazinamide （PZA）-resistant and multidrug-resistant Mycobacterium tuberculosis before and after PZA drug stimulation， and to explore the relationship between PZA-resistant Mycobacterium tuberculosis and pncA gene expression. Methods PZA-res...

Full description

Bibliographic Details
Main Author:	Wang Nan，, Yang Yu, Deng Ling, Wu Hui, Liu Zhihui, Meng Fanrong
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of New Medicine 2023-12-01
Series:	Xin yixue
Subjects:	mycobacterium tuberculosis\|drug resistance\|pyrazinamide\|rifampicin\|pnca
Online Access:	https://www.xinyixue.cn/fileup/0253-9802/PDF/1704251179256-826435266.pdf

Similar Items

Detection of Mutations in <i>pncA</i> in <i>Mycobacterium tuberculosis</i> Clinical Isolates from Nepal in Association with Pyrazinamide Resistance
by: Dipti Shrestha, et al.
Published: (2022-09-01)

Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China
by: Cao Z, et al.
Published: (2019-09-01)

Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates<subtitle>PncA mutations and PZA resistance in M. tuberculosis in Vietnam</subtitle>
by: Nguyen Quang Huy, et al.
Published: (2017-01-01)

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province
by: Shi J, et al.
Published: (2020-08-01)

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China
by: Kun Li, et al.
Published: (2021-01-01)

Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
by: Shi D, et al.
Published: (2022-08-01)

Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
by: Manijeh Kahbazi, et al.
Published: (2018-04-01)

Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
by: Hui Xia, et al.
Published: (2020-01-01)

Colorimetric methods for rapid determination of pyrazinamide resistance
by: Ahmet Ugur Akbal, et al.
Published: (2020-01-01)

Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China
by: Lin S, et al.
Published: (2021-09-01)

Spoligotyping with pncA sequencing strategy conferring the transmission of multidrug-resistant tuberculosis in Egypt
by: Suzan Ismail, et al.
Published: (2019-01-01)

Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China
by: Liu B, et al.
Published: (2024-02-01)

The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide
by: Géraldine Daneau, et al.
Published: (2016-01-01)

Next-generation sequencing to characterise pyrazinamide resistance in Mycobacterium tuberculosis isolates from two Balkan countries
by: Eva Sodja, et al.
Published: (2022-06-01)

pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia
by: Salim Allana, et al.
Published: (2017-03-01)

The Study of PncA Gene Using PCR-RFLP and Allele-Specific PCR Methods in Distinguishing Mycobacterium Bovis from Mycobacterium Tuberculosis
by: Mohammad Reza Allahyar Torkaman, et al.
Published: (2011-12-01)

Exploring of pyrazinamidase recombinant activity from PZA-sensitive and resistant Mycobacterium tuberculosis expressed in Escherichia coli BL21 (DE3)
by: P. Purkan, et al.
Published: (2024-02-01)

Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
by: Yang Che, et al.
Published: (2021-06-01)

Molecular Identification of Mutations Associated with Pyrazinamide-Resistance in Multidrug-Resistant Tuberculosis in Eight Provinces of Iran
by: Jila Moradi, et al.
Published: (2017-11-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line
by: Nicolas de Oliveira Rossini, et al.
Published: (2023-01-01)

Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan
by: Hsin-Ting Huang, et al.
Published: (2023-12-01)

PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
by: R. M. Anthony, et al.
Published: (2018-12-01)

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
by: Ying Zhang, et al.
Published: (2012-07-01)

Activity of Pyrazinamide against <i>Mycobacterium tuberculosis</i> at Neutral pH in PZA-S1 Minimal Medium
by: Wanliang Shi
Published: (2021-07-01)

Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis
by: Mikaela Glader, et al.
Published: (2015-01-01)

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
by: Shulan Dong, et al.
Published: (2024-01-01)

SIMULTANEOUS CONTENT ANALYSIS OF RIFAMPICIN, ISONIAZID, AND PYRAZINAMIDE IN TABLET DOSAGE FORM BY SPECTROPHOTOMETRY ULTRAVIOLET WITH DWM AND RSM
by: Muhammad Andry, et al.
Published: (2022-11-01)

Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study
by: M.J. Nasiri, et al.
Published: (2021-07-01)

A comparative study on the adverse effects of two anti-tuberculosis drugs regimen in initial two-month treatment period
by: Begum Lutfun Nahar, A.K.M. Mosharrof Hossain, M. Monirul Islam and Dipti Rani Saha
Published: (2006-12-01)

A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance
by: Patricia Sheen, et al.
Published: (2017-10-01)

Resistance to pyrazinamide in Mycobacterium tuberculosis complex isolates from previously treated tuberculosis cases in Southwestern Oromia, Ethiopia
by: Getu Balay, et al.
Published: (2024-02-01)

Contributions to the diagnosis of pirazinamide resistance in Mycobacterium tuberculosis
by: Ernesto Montoro, et al.
Published: (2011-12-01)

DEVELOPMENT OF DERIVATIVE SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS DETERMINATION OF PYRAZINAMIDE AND RIFAMPICIN IN CUBOSOME FORMULATION
by: Morgana Souza Marques, et al.
Published: (2021-06-01)

Evaluation of the resistance of Mycobacterium tuberculosis to rifampicin at the regional hospital center of Maradi, Niger Republic
by: Ousmane Abdoulaye, et al.
Published: (2022-01-01)

A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
by: Adam N. Yadon, et al.
Published: (2017-09-01)

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis [version 3; peer review: 1 approved, 2 approved with reservations]
by: Helen McIlleron, et al.
Published: (2024-03-01)

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis [version 2; peer review: 1 approved, 2 approved with reservations]
by: Helen McIlleron, et al.
Published: (2022-11-01)